Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms

Psychiatry Research

Volumn 105, Issue 1-2, 2001, Pages 45-55

  Bonaccorso, Stefania ^a,b,c   Puzella, Antonella ^a   Marino, Valentina ^a   Pasquini, Massimo ^a   Biondi, Massimo ^a   Artini, Marco ^a   Almerighi, Cristiana ^a   Levrero, Massimo ^a   Egyed, Belinda ^b   Bosmans, Eugene ^d   Meltzer, Herbert Y ^c   Maes, Michael ^b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VANDERBILT UNIVERSITY   (United States)

^d Eurogenetics   (Belgium)

Author keywords

Anxiety; Cytokines; Depression; Hepatitis C; Immunotherapy; Interferon alpha; Interleukin 6

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG INDUCED DISEASE; FEMALE; HAMILTON SCALE; HEPATITIS C; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STIMULATION;

ADULT; ANXIETY; CYTOKINES; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2A; MALE; MIDDLE AGED;

EID: 0035894157     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(01)00315-8     Document Type: Article

References (31)

1. Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation
2. Mechanisms of the behavioral effects of interleukin 1
3. Psychological and behavioral effects of interferons
4. Major depression induced by interferon-alpha in patients affected by hepatitis C virus
5. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alpha
6. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat
7. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
8. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alpha
9. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C
10. Serum concentrations of sIL-2r, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha
11. The assessment of anxiety by rating
12. Clinical efficacy of and switch from T helper 2 to T helper 1 cytokine profile after interferon alpha2a monotherapy for human echinococcosis
13. Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentration in the rat brain
14. Two-dimensional analysis of production of IL-6 and TNF-alpha can predict the efficacy of IFN-alpha therapy
15. Brain neurotransmission during peripheral inflammation
16. Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed treatment-naive patients
17. The serotonin hypothesis of major depression
18. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy
19. Cytokines for psychologists: Implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition
20. Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-alpha treatment
21. A new depression scale designed to be sensitive to change
22. Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter
23. Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha
24. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha
25. Reduced preference for sucrose in autoimmune mice: A possible role of interleukin-6
26. Increase in serum interleukin-6, plasma ACTH and serum cortisol levels after systemic interferon-alpha administration
27. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men
28. The effects of interferon-alpha on the production and action of other cytokines
29. Detection of type 2 like T-helper cells in hepatitis C virus infection: Implication for hepatitis C virus chronicity
30. Endotoxin produces a depressive-like episode in rats